These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1820867)

  • 1. Quantification of absorption, intestinal and hepatic first pass effect in a chronic dog model.
    Lemaire M; Bodoky A; Heberer M; Niederberger W
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():132-5. PubMed ID: 1820867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic and intestinal first-pass effects of oltipraz in rats.
    Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG
    Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
    Krause HP; Ahr HJ; Beermann D; Siefert HM; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis and prediction of absorption profile including hepatic first-pass metabolism of N-methyltyramine, a potent stimulant of gastrin release present in beer, after oral ingestion in rats by gastrointestinal-transit-absorption model.
    Kimura T; Iwasaki N; Yokoe JI; Haruta S; Yokoo Y; Ogawara KI; Higaki K
    Drug Metab Dispos; 2000 May; 28(5):577-81. PubMed ID: 10772638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects.
    Shin HS; Bae SK; Lee MG
    Int J Pharm; 2006 Aug; 320(1-2):64-70. PubMed ID: 16730145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition and metabolism of a novel diurea inhibitor of acyl CoA: cholesterol acyltransferase (YM17E) in the rat and dog.
    Uchida T; Nakamura E; Usui T; Imasaki H; Kawakami R; Watanabe T; Higuchi S
    Xenobiotica; 1994 Dec; 24(12):1223-36. PubMed ID: 7771109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and first-pass effects of liquiritigenin in rats: low bioavailability is primarily due to extensive gastrointestinal first-pass effect.
    Kang HE; Cho YK; Jung HY; Choi KY; Sohn SI; Baek SR; Lee MG
    Xenobiotica; 2009 Jun; 39(6):465-75. PubMed ID: 19480552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional pharmacokinetics of 5-bromo-2'-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions.
    Kuan HY; Smith DE; Ensmiger WD; Knol JA; DeRemer SJ; Yang Z; Stetson PL
    Cancer Res; 1996 Oct; 56(20):4724-7. PubMed ID: 8840990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic model of presystemic metabolism.
    Colburn WA; Gibaldi M
    Drug Metab Dispos; 1978; 6(2):193-6. PubMed ID: 26536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol.
    Yoon IS; Choi MK; Kim JS; Shim CK; Chung SJ; Kim DD
    Xenobiotica; 2011 Mar; 41(3):243-51. PubMed ID: 21128757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of gut contents, intestinal wall, and liver on the first pass metabolism and absolute bioavailability of isotretinoin in the dog.
    Cotler S; Buggé CJ; Colburn WA
    Drug Metab Dispos; 1983; 11(5):458-62. PubMed ID: 6138231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
    Han KS; Lee MG
    Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: Contribution of intestinal first-pass effect to low bioavailability in rats.
    Chung HJ; Choi YH; Choi HD; Jang JM; Shim HJ; Yoo M; Kwon JW; Lee MG
    Eur J Pharm Sci; 2006 Mar; 27(4):363-74. PubMed ID: 16387482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of intestinal availability of various drugs in the oral absorption process using portal vein-cannulated rats.
    Matsuda Y; Konno Y; Satsukawa M; Kobayashi T; Takimoto Y; Morisaki K; Yamashita S
    Drug Metab Dispos; 2012 Dec; 40(12):2231-8. PubMed ID: 22930277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary: theoretical predictions of flow effects on intestinal and systemic availability in physiologically based pharmacokinetic intestine models: the traditional model, segregated flow model, and QGut model.
    Pang KS; Chow EC
    Drug Metab Dispos; 2012 Oct; 40(10):1869-77. PubMed ID: 22745334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic fate of the novel antihypertensive drug naftopidil.
    Peter G; Niebch G; Locher M; Borbe HO
    Arzneimittelforschung; 1991 Sep; 41(9):924-31. PubMed ID: 1796920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine.
    Gomez DY; Wacher VJ; Tomlanovich SJ; Hebert MF; Benet LZ
    Clin Pharmacol Ther; 1995 Jul; 58(1):15-9. PubMed ID: 7628178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.